Article

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High Grade Serous Ovarian Cancer

2022-01-05

Abstract excerpt

<title>Abstract</title> <p><underline>Background:</underline> Advanced high grade serous (HGSC) ovarian cancer is treated with either primary surgery followed by chemotherapy or neoadjuvant chemotherapy followed by interval surgery. The decision to proceed with surgery either primarily or after chemotherapy is based on a surgeon’s clinical assessment and prediction of an optimal outcome. Optimal surgery is correl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 015686f7-7246-5adb-b782-4ae9c904ff72
DOI: 10.21203/rs.3.rs-1167716/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High Grade Serous Ovarian CancerDOI 10.21203/rs.3.rs-1167716/v1Read

Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.Semantic proximity Read

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas.Semantic proximity Read

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical OutcomeSemantic proximity Read

Efficient molecular subtype classification of high‐grade serous ovarian cancerSemantic proximity Read

On the predictability of progression-free survival in ovarian cancer from NanoString gene expression dataSemantic proximity Read

Exploration of differential methylation-driven genes to identify key epigenetic genes for prognosis of ovarian serous cystadenocarcinomaSemantic proximity Read

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian CancerSemantic proximity Read

Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.Semantic proximity Read

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput DataSemantic proximity Read

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.Semantic proximity Read

Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian CancerSemantic proximity Read

Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian CancerSemantic proximity Read